Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Consulting agrmnt
Inv. presentation
Appointed director
CC transcript

Neurotrope, Inc. (NTRP) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/29/2021 SC 13G/A INTRACOASTAL CAPITAL, LLC reports a 0% stake in Neurotrope, Inc.
12/07/2020 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failur...
Docs: "SEPARATION AND DISTRIBUTION AGREEMENT",
"TAX MATTERS AGREEMENT",
"Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals"
12/02/2020 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
11/25/2020 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
11/24/2020 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
11/24/2020 8-K Other Events  Interactive Data
11/20/2020 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
11/20/2020 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Neurotrope, Inc. Approves Spin-Off of Neurotrope Bioscience, Inc. and Sets Record and Distribution Dates"
11/09/2020 10-Q Quarterly Report for the period ended September 30, 2020
09/30/2020 425 Form 425 - Prospectuses and communications, business combinations:
09/30/2020 8-K Quarterly results
09/30/2020 425 Form 425 - Prospectuses and communications, business combinations:
09/30/2020 8-K Quarterly results
08/10/2020 10-Q Quarterly Report for the period ended June 30, 2020
07/29/2020 8-K Quarterly results
07/24/2020 8-K Quarterly results
07/24/2020 425 Form 425 - Prospectuses and communications, business combinations:
07/23/2020 8-K Quarterly results
07/23/2020 425 Form 425 - Prospectuses and communications, business combinations:
06/12/2020 10-Q Quarterly Report for the period ended March 31, 2020
05/28/2020 8-K Conference call transcript
Docs: "Conference Call Transcript held on May 28, 2020"
05/28/2020 425 Form 425 - Prospectuses and communications, business combinations:
05/18/2020 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger and Reorganization, by and among Petros, Neurotrope, Merger Sub 1, Merger Sub 2 and Metuchen",
"Form of Neurotrope Voting Agreement, by and between Metuchen and certain stockholders of Neurotrope",
"Form of Metuchen Voting Agreement, by and between Neurotrope and certain unitholders of Metuchen",
"Form of Lock-Up Agreement, by and between Petros, Neurotrope, Metuchen and certain securityholders of Neurotrope and Metuchen",
"Consent of EisnerAmper LLP, Metuchen’ s independent registered public accounting firm",
"Neurotrope and Metuchen Pharmaceuticals Announce Merger Agreement to Form Petros Pharmaceuticals, a Men’ s Health Company",
"“Metuchen Business” section excerpt",
"“Metuchen Management’ s Disclosure and Analysis of Financial Condition and Results of Operations” section excerpt",
"“Risk Factors” section excerpt",
"“Fairness Opinion of Gemini Partners LLC” section excerpt"
05/18/2020 425 Form 425 - Prospectuses and communications, business combinations:
05/11/2020 8-K Other Events
04/27/2020 EFFECT Form EFFECT - Notice of Effectiveness:
04/24/2020 424B2 Form 424B2 - Prospectus [Rule 424(b)(2)]:
04/17/2020 S-3 Form S-3 - Registration statement under Securities Act of 1933:
03/13/2020 10-K Annual Report for the period ended December 31, 2019
02/27/2020 8-K Quarterly results
02/26/2020 8-K Quarterly results
02/14/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/30/2020 SC 13G INTRACOASTAL CAPITAL, LLC reports a 10% stake in Neurotrope, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy